[Featured image above: New Guinea Ebola vaccine trials; WHO/S. Hawkey] The views expressed in this blog post belong solely to its author…
-
post Opinion: Who should lead WHO (Pt. 3 of 3)? Dr. David Nabarro, “a frontline clinician and global health leader”
-
post #WorldMalariaDay: can nets and sprays keep the bugs away?
By Abraar Karan MD, Harvard T.H. Chan School of Public Health Many nights, I wondered what was worse: risking a bite from…
-
post Opinion: Who should lead WHO (pt 2 of 3)? Why I support Pakistan’s “Great Reformer”
The views expressed in this blog post belong solely to its author and do not necessarily reflect the views of PLOS or…
-
post Trump wants deep cuts to international aid: the uncalculated costs of global health insecurity
By Ana Rita Sequeira In the last decade, the United States has played a leading funder role in the preparedness and…
-
post Why Mentors Matter: Global Health Research Mentorship in LMICs #WorldHealthDay2017
By Abraar Karan MD, Harvard T.H. Chan School of Public Health Mentorship in global health is severely lacking for young leaders who…
-
post Opinion: Who should lead WHO (Pt 1 of 3)? Dr. Tedros, nominee of the Government of Ethiopia.
The views expressed in this blog post belong solely to its author and do not necessarily reflect the views of PLOS or…
-
post Ending a Global Epidemic: Tuberculosis in Children #UnitetoEndTB
“When my daughter got sick, I took her to a clinic in my neighborhood. They gave her cough syrup for seven days…
-
post Talking Drug Prices, Pt 4 Drug pricing is out of control, what should be done? By James Love
Welcome to part four in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our…
-
post Talking Drug Prices Pt 2: This Blog Post Will Cost You by Jessica Wapner
Welcome to the second in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one…
-
post Talking about Drug Prices & Access to Medicines Pt 1: By Els Torreele, Open Society Foundations
Welcome to a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our bloggers…